National Specialty Pharmacy, LLC v. Padhye

Background

National Specialty Pharmacy, LLC (NSP) is a compounding pharmacy that develops, compounds, markets, and distributes medicines. The complaint named four former employees—Sameer Padhye, Maybelline Sana, Rayne Bridges, and Daniel Brown—along with Enlil, Inc., Coligomed, Inc., and Abhinay Padhye. The opinion describes Enlil as owned by Sameer Padhye and Coligomed as owned by his brother, Abhinay Padhye.

NSP alleged that the former employees took confidential information and other property and transferred it to the affiliated businesses. It also alleged that defendants modified NSP’s corporate records without permission and that several former employees improperly accessed NSP systems before and after their employment ended. Four defendants filed motions to dismiss.

Rayne Bridges: Personal Jurisdiction

Bridges represented herself and argued that the court lacked personal jurisdiction over her and that NSP had failed to state a claim. She stated that she was a Nevada resident, had never worked in California for NSP, and had no other California contacts.

Her employment agreement included a California governing-law provision and a clause consenting to personal jurisdiction and venue in California courts for lawsuits permitted under the agreement. Applying California law, the court held that the California forum-selection clause was unreasonable because California had no logical connection to Bridges or her work for NSP. The court therefore also held that the related consent-to-jurisdiction provision could not be enforced.

The court further held that it lacked general personal jurisdiction because Bridges did not live in California and lacked specific personal jurisdiction because the complaint did not clearly allege that she took intentional actions expressly aimed at California or knew those actions would likely cause harm there. The court granted her motion and dismissed all claims against her under Federal Rule of Civil Procedure 12(b)(2), without prejudice to refiling them in an appropriate jurisdiction.

Maybelline Sana: Personal Jurisdiction

Sana also lived in Nevada, and the opinion states that her employment agreement did not contain a California forum-selection clause. The court concluded that jurisdiction could exist only if NSP’s claims arose from Sana’s actions expressly aimed at California and likely to cause harm there.

The court rejected NSP’s reliance on alleged California contacts involving other people or entities, including alleged contacts involving Sameer Padhye, Enlil, and Coligomed. The court also found that NSP’s allegations that the improper activities occurred in California while Padhye worked remotely with Sana did not identify specific conduct by Sana that targeted California. The court granted Sana’s motion to dismiss for lack of personal jurisdiction, without prejudice to refiling claims against her in an appropriate forum.

Enlil and Coligomed: Failure to State a Claim

Enlil and Coligomed did not challenge personal jurisdiction. They moved under Rule 12(b)(6), which allows dismissal when a complaint does not state a legally sufficient claim.

The court dismissed NSP’s tortious-interference claims with leave to amend because the complaint did not identify the contracts allegedly affected, which defendants interfered with them, or how the interference occurred.

The court considered conversion and conspiracy to convert together because conspiracy is not a separate cause of action but an alternative theory of liability. It dismissed those claims with leave to amend because the complaint did not identify particular property allegedly converted by either company or specific acts by either company that wrongfully converted property. The allegations that the companies acted as conduits, recipients, or beneficiaries of improperly obtained property were too vague and conclusory.

The court also dismissed NSP’s claim under the federal Defend Trade Secrets Act with leave to amend. NSP described alleged trade secrets using broad categories such as vendor and partner information, formulas, business processes, pricing information, marketing methods, and computer systems. The court held that these descriptions did not identify specific tangible trade-secret material. Any amended complaint would need to identify the specific material claimed to be a trade secret and clearly allege how Enlil or Coligomed misappropriated it.

Finally, the court dismissed NSP’s California Unfair Competition Law claim with leave to amend. The complaint alleged generally that all defendants engaged in unlawful, unfair, fraudulent, deceptive, untrue, and misleading behavior, but it did not identify specific actions by Enlil or Coligomed that violated the law.

Disposition

The court granted all four motions to dismiss. Bridges and Sana were dismissed from the action because the court lacked personal jurisdiction over them. NSP could file an amended complaint attempting to correct the pleading problems in its claims against Enlil and Coligomed, with the amended complaint due June 3, 2024, if NSP chose to file one.